Kepro Holland OÜ
- Registry code
- 16386970
- VAT number
- EE102443662
- Address
- Harju maakond, Tallinn, Lasnamäe linnaosa, Nuia tn 2, 11415
- Registered
- 10.12.2021 · 4 yrs
- Activity
- Wholesale of pharmaceutical goods 46461
- Additional activities
- Äri- ja muu juhtimisalane nõustamine, Rental and operating of own or leased real estate
- Capital
- 2 500 €
- k•••@g•••.comLog in to see
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
2 persons
| Board 1 | ||
|---|---|---|
| Veiko Saluste6 companiesno tax debt | Personal ID ↗ | 21.01.2025 |
| Other persons 1 | ||
| Ants Karu8 companiesno tax debtProcurator | Personal ID ↗ | 10.12.2021 |
| Shareholders 1 | ||
| Kepro B.V. | 100,0% 2 500 € | 01.09.2023 |
| Beneficial owners 1 | ||
| Anthonie Sebastiaan Tesinkkaudne osalus | 13.12.2021 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 579 039 € | ▲ 50% | — | — | — |
| 2026 Q1 | 245 010 € | ▲ 113% | 7 574 € | 6 782 € | — |
| 2025 Q4 | 683 477 € | ▲ 498% | 11 661 € | 15 581 € | 1 |
| 2025 Q3 | 228 825 € | ▲ 100% | 11 492 € | 28 591 € | 2 |
| 2025 Q2 | 384 889 € | ▲ 237% | 11 576 € | 27 457 € | 2 |
| 2025 Q1 | 115 269 € | ▼ 53% | 14 905 € | 33 155 € | 3 |
| 2024 Q4 | 114 223 € | ▲ 5% | 14 462 € | 32 368 € | 3 |
| 2024 Q3 | 114 223 € | ▼ 66% | 14 462 € | 30 228 € | 3 |
| 2024 Q2 | 114 223 € | ▲ 216% | 14 462 € | 32 518 € | 3 |
| 2024 Q1 | 246 427 € | ▲ 620% | 25 508 € | 65 060 € | 3 |
| 2023 Q4 | 109 260 € | ▲ 765% | 25 540 € | 39 086 € | 4 |
| 2023 Q3 | 338 382 € | ▲ 4222% | 25 541 € | 91 957 € | 4 |
Show full history (18 quarters)
| 2023 Q2 | 36 141 € | ▼ 69% | 25 555 € | 23 571 € | 4 |
| 2023 Q1 | 34 248 € | ▼ 99% | 24 221 € | 24 299 € | 4 |
| 2022 Q4 | 12 624 € | 24 028 € | 24 118 € | 4 | |
| 2022 Q3 | 7 830 € | 21 614 € | 20 514 € | 4 | |
| 2022 Q2 | 115 577 € | 14 712 € | 30 353 € | 4 | |
| 2022 Q1 | 3 587 675 € | 1 053 € | 0 € | 2 |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
4 yr
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Sales revenue | 1,7 m € | ▲ 272% | 459 k € | ▲ 6% | 434 k € | ▲ 28% | 340 k € |
| Profit | 327 k € | ▲ 358% | 71 261 € | ▼ 63% | 192 k € | ▲ into profit | -250 k € |
| Profit margin | 19,1% | 15,5% | 44,2% | -73,4% | |||
| Retained earnings | 13 152 € | ▲ into profit | -58 109 € | ▲ 77% | -250 k € | — | |
| Cash | 43 967 € | ▼ 78% | 203 k € | ▼ 43% | 356 k € | ▲ 342% | 80 574 € |
| Current assets | 527 k € | ▲ 40% | 377 k € | ▼ 52% | 789 k € | ▲ 162% | 302 k € |
| Fixed assets | 1 471 € | ▼ 100% | 3,3 m € | ▼ 2% | 3,4 m € | ▼ 7% | 3,7 m € |
| Assets | 528 k € | ▼ 86% | 3,7 m € | ▼ 12% | 4,2 m € | ▲ 6% | 4,0 m € |
| Current liabilities | 126 k € | ▲ 104% | 61 966 € | ▼ 84% | 380 k € | ▲ 9% | 350 k € |
| Long-term liabilities | 0 € | ▼ 100% | 3,5 m € | ▼ 7% | 3,8 m € | ▼ 2% | 3,9 m € |
| Total liabilities | 126 k € | ▼ 97% | 3,6 m € | ▼ 14% | 4,2 m € | ▼ 1% | 4,2 m € |
| Equity | 402 k € | ▲ 432% | 75 652 € | ▲ 17× | 4 391 € | ▲ into profit | -248 k € |
| Labour costs | -101 k € | ▲ 27% | -139 k € | ▲ 43% | -246 k € | ▼ 31% | -188 k € |
| Employees | 2 | ▼ 33% | 3 | ▼ 25% | 4 | 0% | 4 |
| Filed | 14.07.2026 | 31.01.2025 | 19.02.2024 | 03.10.2023 | |||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Wholesale of pharmaceutical goods main activity | 46461 | 1 321 036 € | 78% |
| Rental and operating of own or leased real estate | 68201 | 226 369 € | 13% |
| Äri- ja muu juhtimisalane nõustamine | 70201 | 144 000 € | 9% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
12
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Wholesale of pharmaceutical goods
20
| # | Company | Revenue |
|---|---|---|
| 1 | MAGNUM MEDICAL OÜ | 295,0 m € |
| 2 | TAMRO EESTI OÜ | 239,6 m € |
| 3 | Novo Nordisk Estonia OÜ | 37,0 m € |
| 4 | SONA-PHARM OÜ | 36,9 m € |
| 5 | Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal | 30,7 m € |
| 6 | Aktsiaselts Magnum Veterinaaria | 28,6 m € |
| 7 | Osaühing Zoovetvaru | 21,5 m € |
| 8 | Osaühing Berlin-Chemie Menarini Eesti | 17,3 m € |
| 9 | Globalex Pharma OÜ | 16,1 m € |
| 10 | OÜ Micotrade | 15,8 m € |
| 11 | Apteegikaubanduse Hulgimüük OÜ | 12,2 m € |
| 12 | Aktsiaselts FORANS EESTI | 8,0 m € |
| 13 | DAAAK Pharma Int. AS | 7,6 m € |
| 14 | Gerdavit OÜ | 7,2 m € |
| 15 | AS Oribalt Tallinn | 7,0 m € |
| 16 | Aktsiaselts PAIRA | 6,2 m € |
| 17 | ORNYX OÜ | 5,1 m € |
| 18 | Pharm Origin OÜ | 5,1 m € |
| 19 | First Pharma OÜ | 4,9 m € |
| 20 | Hiirehernes OÜ | 4,8 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
12
| Date | Type | Content |
|---|---|---|
| 27.04.2026 | Entry | Amendment entry |
| 10.04.2026 | Order to remedy deficiencies | Amendment entry |
| 02.04.2025 | Entry | Amendment entry |
| 21.01.2025 | Entry | Amendment entry |
| 16.04.2024 | Entry | Amendment entry |
| 28.09.2023 | Entry | Amendment entry |
| 01.09.2023 | Entry | Amendment entry |
| 28.07.2023 | Entry | Amendment entry |
| 09.06.2023 | Entry | Amendment entry |
| 02.05.2023 | Entry | Amendment entry |
| 29.03.2022 | Entry | Amendment entry |
| 10.12.2021 | Entry | First entry |